Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

AZ sets price of new lung cancer drug Tagrisso

AZ sets price of new lung cancer drug Tagrisso The drug is a third-generation EGFR inhibitor, which is designed to overcome resistance to other drugs in the class such as Roche/Astellas' $2bn-a-year Tarceva (erlotinib), AZ's

Astellas sells dermatology unit to Leo for €675m

Astellas sells dermatology unit to Leo for €675m The overarching aim is to prepare for the forthcoming patent expiries on big-selling drugs Vesicare (solifenacin succinate) for overactive bladder and cancer therapy Tarceva (erlotinib).

Boehringer takes third-generation NSCLC drug into pivotal trials

Boehringer takes third-generation NSCLC drug into pivotal trials Tarceva (erlotinib) and AstraZeneca's Iressa (gefitinib), as well as Boehringer's own second-generation drug Giotrif (afatinib).

Oncology directions

Oncology directions Most of the drugs in lung cancer score four, but Roche's lung cancer drug Tarceva (erlotinib) scored just one.

Iressa set for US market return after FDA approval

Iressa set for US market return after FDA approval other first-generation EGFR inhibitors such as Roche/OSI's Tarceva (erlotinib) as well as newer drugs such as Boehringer Ingelheim's Giotrif (afatinib).

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics